IL-7 Reporter HEK 293 Cells

HEK-Blue™ IL-7 Cells signaling pathway

Interleukin-7 Reporter Cells

HEK-Blue™ IL-7 cells were engineered from the human embryonic kidney HEK 293 cell line to detect bioactive interleukin-7 (IL-7) by monitoring the activation of the JAK/STAT5 pathway.  IL-7 is a secreted cytokine that plays an essential role in B cell and T cell development and function [1-4]. 

 More details

Cell line description:

HEK-Blue™ IL-7 cells were generated by stable overexpression of the genes encoding the alpha chain of human IL-7 receptor (IL-7Rα), human IL-2Rγ, human JAK3, human STAT5b, and a STAT5-inducible secreted embryonic alkaline phosphatase (SEAP) reporter. STAT5-dependent SEAP activity is readily assessable in the supernatant using QUANTI-Blue™ Solution, a detection reagent.  Of note, HEK-Blue™ IL-7 cells also respond to human type II interferons (IFN-γ; see Figures).  However, they do not respond to human type I IFNs (IFN-α/IFN-β), as they are knock-out for IFNAR2.

Features of HEK-Blue™ IL-7 cells:

• Fully functional IL-7 signaling pathway
• Readily assessable STAT5-inducible SEAP reporter activity
• The stability for 20 passages has been verified
• Functionally tested and guaranteed mycoplasma-free

Applications of HEK-Blue™ IL-7 cells:

• Detection of human and murine IL-7
• Screening of anti-IL-7 and anti-IL-7R antibodies

References:

1. Lin J. et al., 2017. The role of IL-7 in Immunity and Cancer. Anticancer Res. 37(3):963-7.
2. Ribeir D. et al., 2018. STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells. Blood Adv. 2(17):2199-213.
3. Mackall C.L. et al., 2011. Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol. 11(5):330-42.
4. Barata J.T. et al., 2019. Flip the coin: IL-7 and IL-7R in health and disease. Nat Immunol. 20(12):1584-93.

Figures

Validation of the expression of human IL-7Rα by HEK-Blue™ IL-7 cells.
5 x 10⁵ cells were incubated with either an APC-conjugated isotype control (blue) or an APC-conjugated Anti-IL-7Rα mAb (red) for 30 minutes. The binding affinity was then measured using flow cytometry.

Dose-response of HEK-Blue™ IL-7 cells to recombinant IL-7.
Cells were stimulated with increasing concentrations of recombinant human IL-7 (hIL-7) and murine IL-7 (mIL-7). After overnight incubation, the STAT5 response was determined using QUANTI‑Blue™ Solution, a SEAP detection reagent. The optical density (OD) at 630 nm is shown as mean ± SEM.

Dose-dependent inhibition of HEK‑Blue™ IL-7 cellular response using a neutralizing antibody against IL-2Rγ, a subunit of IL‑7R.
The antibody was incubated with HEK-Blue™ IL-7 cells for 2 hours prior to the addition of hIL-7 (0.3 ng/ml). After overnight incubation, SEAP activity in the cell culture supernatant was assessed using QUANTI-Blue™ Solution. Data are shown as a percentage (%) of activity.

Response of HEK-Blue™ IL-7 cells to a panel of cytokines.
Cells were stimulated with various human and murine recombinant cytokines: 1 ng/ml of hIL-7 or mIL-7, and 100 ng/ml hIL-2, hIL-4, hIL‑6, hIL-9, mIL-9, hIL‑15, hIL-21, or hIL-27, and 1000 U/ml hIFN-α, and 10 ng/ml hIFN-γ. After overnight incubation, SEAP activity was assessed using QUANTI‑Blue™ Solution. The optical density (OD) at 630 nm is shown as mean ± SEM.

Specifications

Antibiotic resistance: Blasticidin, Hygromycin, Puromycin, Zeocin®

Growth medium: DMEM, 4.5 g/l glucose, 2 mM L-glutamine, 10% (v/v) heat-inactivated fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 100 μg/ml Normocin™

Guaranteed mycoplasma-free

Specificity: human and murine IL-7

Detects human and murine IL-7: 100 pg - 100 ng/ml

This product is covered by a Limited Use License (See Terms and Conditions).

Contents

• 1 vial containing 3-7 x 10⁶ cells
• 2 x 1 ml HEK-Blue™ Selection (250X concentrate)
• 1 ml of Puromycin (10 mg/ml)
• 1 ml Normocin™ (50 mg/ml)
• 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution, a SEAP detection reagent)

Shipped on dry ice (Europe, USA, Canada and some areas in Asia)

Details

Interleukin 7 (IL-7) is a secreted cytokine that plays an essential role in B cell and T cell development and function [1]. IL-7 signals through the heterodimeric cell surface IL-7 receptor (IL-7R) consisting of IL-7Rα (also called CD127) and IL-2Rγ (also called the common γ-chain or CD132).
The binding of IL-7 to its receptor triggers three main signaling pathways: JAK/STAT, PI3K, and MAPK/ERK [1‑3]. Of note, IL-7R-mediated signaling triggers proliferative and anti‑apoptotic signals mainly by activating the JAK/STAT pathway [1-3]. IL-7/IL-7R signaling, which regulates lymphocyte growth and survival, has been implicated in the development of malignancies and autoimmune diseases [1-4].

1. Lin J. et al., 2017. The role of IL-7 in Immunity and Cancer. Anticancer Res. 37(3):963-7.
2. Ribeir D. et al., 2018. STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells. Blood Adv. 2(17):2199-213.
3. Mackall C.L. et al., 2011. Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol. 11(5):330-42.
4. Barata J.T. et al., 2019. Flip the coin: IL-7 and IL-7R in health and disease. Nat Immunol. 20(12):1584-93.

FAQ Cell Lines

Any questions about our cell lines ? Visit our frequently asked questions page